The Food and Drug Administration and the Centers for Disease Control and Prevention this morning called for a pause of the Johnson & Johnson COVID vaccine following some reports of "a rare and severe type of blood clot" after receiving the shot.
The federal health agencies say they're pausing the single-shot vaccine "out of an abundance of caution." There have been 6.8 million Johnson & Johnson shots administered in the U.S. and six people have experienced the blood clot within two weeks of receiving the shot. All of them are women between the ages of 18 and 48, including one who died. (NY Times)